Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-01

FDA Approved: TALICIA — Supplemental Application (RedHill Biopharma Ltd)

View source ↗

Summary

The FDA approved a supplemental application for TALICIA, a fixed-dose combination of omeprazole magnesium, amoxicillin, and rifabutin developed by RedHill Bioph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TALICIA (Omeprazole magnesium, amoxicillin and rifabutin)

Snippet

SUPPL AP for TALICIA (OMEPRAZOLE MAGNESIUM, AMOXICILLIN AND RIFABUTIN)